Liposomal Mitoxantrone Hydrochloride Injection,Cyclophosphamide, Vincristine and Prednisone in the Treatment of PTCL
Clinical trial NCT04548700 · TERMINATED
Trial details
- NCT number
- NCT04548700
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-24
- Primary completion
- 2023-06-30
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.